MediciNova

More Info

General Info

MediciNova is a publicly traded biopharmaceutical company focused on acquiring and developing novel small-molecule therapeutics for the treatment of diseases with unmet need with a specific focus on the United States market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which it believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. The company s pipeline includes six clinical-stage compounds for the treatment of status asthmaticus, multiple sclerosis, asthma, interstitial cystitis, solid tumor cancer, generalized anxiety disorder, preterm labor and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. Its current strategy is to focus its resources on the development and commercialization of two prioritized assets in its development pipeline, MN-221 for the treatment of status asthmaticus and MN-166 for the treatment of multiple sclerosis. MediciNova maintains a location in San Diego, Calif.

Email

Email Business

BBB Rating

A+

BBB Rating and Accreditation information may be delayed up to a week.

Extra Phones

Phone: (650) 529-7472

Fax: (858) 404-0048

Location

4275 Executive Square

Neighborhoods

University City, Northern San Diego

AKA

Medicnova Inc

Medikine, Inc.

Medici Nova Inc

Other Link

https://www.medikine.com

Other Email

Email Business

Category

Pharmaceutical Products

Reviews

Details

Phone: (858) 373-1500

Address: 4275 Executive Sq Ste 300, La Jolla, CA 92037

Website: https://www.medikine.com